Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Jolicoeur EM, O'Neill WW, Hellkamp A, Hamm CW, Holmes DR Jr, Al-Khalidi HR, Patel MR, Van de Werf FJ, Pieper K, Armstrong PW, Granger CB; APEX-AMI Investigators. Jolicoeur EM, et al. Among authors: hellkamp a. Eur Heart J. 2009 Nov;30(21):2575-83. doi: 10.1093/eurheartj/ehp279. Epub 2009 Jul 11. Eur Heart J. 2009. PMID: 19596659 Clinical Trial.
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
Roe MT, Granger CB, Puma JA, Hellkamp AS, Hochman JS, Ohman EM, White HD, Van de Werf F, Armstrong PW, Ellis SG, Califf RM, Topol EJ. Roe MT, et al. Among authors: hellkamp as. Am J Cardiol. 2001 Dec 15;88(12):1403-6, A6. doi: 10.1016/s0002-9149(01)02119-1. Am J Cardiol. 2001. PMID: 11741559 No abstract available.
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA. Lewis EF, et al. Among authors: hellkamp as. Eur Heart J. 2008 Mar;29(6):748-56. doi: 10.1093/eurheartj/ehn062. Epub 2008 Feb 28. Eur Heart J. 2008. PMID: 18308687 Clinical Trial.
Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study.
Madan M, Nikhil J, Hellkamp AS, Pieper KS, Labinaz M, Cohen EA, Buller CE, Cantor WJ, Seidelin P, Ducas J, Carere RG, Natarajan MK, O'Shea JC, Tcheng JE; ESPRIT Investigators. Madan M, et al. Among authors: hellkamp as. Can J Cardiol. 2009 Aug;25(8):e269-72. doi: 10.1016/s0828-282x(09)70120-5. Can J Cardiol. 2009. PMID: 19668787 Free PMC article.
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Piccini JP, Al-Khatib SM, Hellkamp AS, Anstrom KJ, Poole JE, Mark DB, Lee KL, Bardy GH. Piccini JP, et al. Heart Rhythm. 2011 Mar;8(3):393-400. doi: 10.1016/j.hrthm.2010.11.033. Epub 2010 Nov 23. Heart Rhythm. 2011. PMID: 21109025 Free PMC article. Clinical Trial.
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".
French JK, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, Hellkamp AS, Stebbins A, Holmes DR, Hochman JS, Granger CB, Mahaffey KW. French JK, et al. Among authors: hellkamp as. Am Heart J. 2011 Jul;162(1):89-97. doi: 10.1016/j.ahj.2011.04.009. Am Heart J. 2011. PMID: 21742094 Clinical Trial.
Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?
Al-Khatib SM, Hellkamp AS, Hernandez AF, Fonarow GC, Thomas KL, Al-Khalidi HR, Heidenreich PA, Hammill S, Yancy C, Peterson ED; Get With the Guidelines Steering Committee and Hospitals. Al-Khatib SM, et al. Among authors: hellkamp as. Circulation. 2012 Mar 6;125(9):1094-101. doi: 10.1161/CIRCULATIONAHA.111.066605. Epub 2012 Jan 27. Circulation. 2012. PMID: 22287589 Free PMC article.
Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials.
Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, Anstrom KJ, Curtis J, Al-Khalidi H, Curtis LH, Heidenreich P, Peterson ED, Sanders G, Clapp-Channing N, Lee KL, Moss AJ. Al-Khatib SM, et al. Among authors: hellkamp a. JAMA. 2013 Jan 2;309(1):55-62. doi: 10.1001/jama.2012.157182. JAMA. 2013. PMID: 23280225 Free PMC article.
181 results